247 related articles for article (PubMed ID: 30333223)
1. Body Fatness, Adipose Tissue Compartments, and Biomarkers of Inflammation and Angiogenesis in Colorectal Cancer: The ColoCare Study.
Himbert C; Ose J; Nattenmüller J; Warby CA; Holowatyj AN; Böhm J; Lin T; Haffa M; Gigic B; Hardikar S; Scherer D; Zielske L; Schrotz-King P; Kölsch T; Siegel EM; Shibata D; Ulrich A; Schneider M; Hursting SD; Kauczor HU; Ulrich CM
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):76-82. PubMed ID: 30333223
[TBL] [Abstract][Full Text] [Related]
2. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics profiling of visceral and abdominal subcutaneous adipose tissue in colorectal cancer patients: results from the ColoCare study.
Ose J; Holowatyj AN; Nattenmüller J; Gigic B; Lin T; Himbert C; Habermann N; Achaintre D; Scalbert A; Keski-Rahkonen P; Böhm J; Schrotz-King P; Schneider M; Ulrich A; Kampman E; Weijenberg M; Gsur A; Ueland PM; Kauczor HU; Ulrich CM
Cancer Causes Control; 2020 Aug; 31(8):723-735. PubMed ID: 32430684
[TBL] [Abstract][Full Text] [Related]
4. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer.
Guiu B; Petit JM; Bonnetain F; Ladoire S; Guiu S; Cercueil JP; Krausé D; Hillon P; Borg C; Chauffert B; Ghiringhelli F
Gut; 2010 Mar; 59(3):341-7. PubMed ID: 19837679
[TBL] [Abstract][Full Text] [Related]
5. Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy.
Grignol VP; Smith AD; Shlapak D; Zhang X; Del Campo SM; Carson WE
Surg Oncol; 2015 Dec; 24(4):353-8. PubMed ID: 26690825
[TBL] [Abstract][Full Text] [Related]
6. Validating quantitative obesity measurements in colorectal cancer patients.
Balentine CJ; Marshall C; Robinson C; Wilks J; Anaya D; Albo D; Berger DH
J Surg Res; 2010 Nov; 164(1):18-22. PubMed ID: 20828744
[TBL] [Abstract][Full Text] [Related]
7. Inflammation- and angiogenesis-related biomarkers are correlated with cancer-related fatigue in colorectal cancer patients: Results from the ColoCare Study.
Himbert C; Ose J; Lin T; Warby CA; Gigic B; Steindorf K; Schrotz-King P; Abbenhardt-Martin C; Zielske L; Boehm J; Ulrich CM
Eur J Cancer Care (Engl); 2019 Jul; 28(4):e13055. PubMed ID: 31016796
[TBL] [Abstract][Full Text] [Related]
8. Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer.
Slaughter KN; Thai T; Penaroza S; Benbrook DM; Thavathiru E; Ding K; Nelson T; McMeekin DS; Moore KN
Gynecol Oncol; 2014 Apr; 133(1):11-5. PubMed ID: 24680585
[TBL] [Abstract][Full Text] [Related]
9. CT-based compartmental quantification of adipose tissue versus body metrics in colorectal cancer patients.
Nattenmueller J; Hoegenauer H; Boehm J; Scherer D; Paskow M; Gigic B; Schrotz-King P; Grenacher L; Ulrich C; Kauczor HU
Eur Radiol; 2016 Nov; 26(11):4131-4140. PubMed ID: 26852215
[TBL] [Abstract][Full Text] [Related]
10. Clinical Impact of Abdominal Fat Distribution on Prognosis After Esophagectomy for Esophageal Squamous Cell Carcinoma.
Okamura A; Watanabe M; Mine S; Nishida K; Imamura Y; Kurogochi T; Kitagawa Y; Sano T
Ann Surg Oncol; 2016 Apr; 23(4):1387-94. PubMed ID: 26668084
[TBL] [Abstract][Full Text] [Related]
11. Semiautomated Measure of Abdominal Adiposity Using Computed Tomography Scan Analysis.
Srikumar T; Siegel EM; Gu Y; Balagurunathan Y; Garcia AL; Chen YA; Zhou JM; Zhao X; Gillies R; Clark W; Gamenthaler A; Choi J; Shibata D
J Surg Res; 2019 May; 237():12-21. PubMed ID: 30694786
[TBL] [Abstract][Full Text] [Related]
12. Correlation between Non-Alcoholic Fatty Liver Disease and Visceral Adipose Tissue in Non-Obese Chinese Adults: A CT Evaluation.
Yu AH; Duan-Mu YY; Zhang Y; Wang L; Guo Z; Yu YQ; Wang YS; Cheng XG
Korean J Radiol; 2018; 19(5):923-929. PubMed ID: 30174482
[TBL] [Abstract][Full Text] [Related]
13. Visceral obesity is associated with outcomes of total mesorectal excision for rectal adenocarcinoma.
Ballian N; Lubner MG; Munoz A; Harms BA; Heise CP; Foley EF; Kennedy GD
J Surg Oncol; 2012 Mar; 105(4):365-70. PubMed ID: 21751219
[TBL] [Abstract][Full Text] [Related]
14. High serum levels of C-reactive protein (CRP) predict beneficial decrease of visceral fat in obese females after sleeve gastrectomy.
Carbone F; Nulli Migliola E; Bonaventura A; Vecchié A; De Vuono S; Ricci MA; Vaudo G; Boni M; Dallegri F; Montecucco F; Lupattelli G
Nutr Metab Cardiovasc Dis; 2018 May; 28(5):494-500. PubMed ID: 29502925
[TBL] [Abstract][Full Text] [Related]
15. Impact of subcutaneous and visceral fat adiposity in patients with colorectal cancer.
Kim JM; Chung E; Cho ES; Lee JH; Shin SJ; Lee HS; Park EJ; Baik SH; Lee KY; Kang J
Clin Nutr; 2021 Nov; 40(11):5631-5638. PubMed ID: 34662848
[TBL] [Abstract][Full Text] [Related]
16. One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare Study.
Kiblawi R; Holowatyj AN; Gigic B; Brezina S; Geijsen AJMR; Ose J; Lin T; Hardikar S; Himbert C; Warby CA; Böhm J; Bours MJL; van Duijnhoven FJB; Gumpenberger T; Kok DE; Koole JL; van Roekel EH; Schrotz-King P; Ulvik A; Gsur A; Habermann N; Weijenberg MP; Ueland PM; Schneider M; Ulrich A; Ulrich CM; Playdon M
Br J Nutr; 2020 May; 123(10):1187-1200. PubMed ID: 32019627
[TBL] [Abstract][Full Text] [Related]
17. Impact of body mass index and visceral adiposity on outcomes in colorectal cancer.
Yamamoto N; Fujii S; Sato T; Oshima T; Rino Y; Kunisaki C; Masuda M; Imada T
Asia Pac J Clin Oncol; 2012 Dec; 8(4):337-45. PubMed ID: 22897609
[TBL] [Abstract][Full Text] [Related]
18. Opportunistic use of radiological measures of visceral adiposity for assessment of risk of colorectal adenoma.
Ng ZQ; Wijesuriya R; Misur P; Tan JH; Moe KS; Theophilus M
ANZ J Surg; 2020 Nov; 90(11):2298-2303. PubMed ID: 32501646
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Computed Tomography-based Abdominal Adiposity Indexes as Predictors of Non-alcoholic Fatty Liver Disease Among Middle-aged Korean Men and Women.
Baek J; Jung SJ; Shim JS; Jeon YW; Seo E; Kim HC
J Prev Med Public Health; 2020 Jul; 53(4):256-265. PubMed ID: 32752595
[TBL] [Abstract][Full Text] [Related]
20. Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research.
Doyle SL; Bennett AM; Donohoe CL; Mongan AM; Howard JM; Lithander FE; Pidgeon GP; Reynolds JV; Lysaght J
Nutr Res; 2013 Mar; 33(3):171-9. PubMed ID: 23507222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
